<i>In Situ</i> Crosslinked Hydrogel Depot for Sustained Antibody Release Improves Immune Checkpoint Blockade Cancer Immunotherapy
The therapeutic inhibition of immune checkpoints, including cytotoxic T lymphocyte-associated protein (CTLA)-4 and programmed cell death 1 (PD-1), through the use of function blocking antibodies can confer improved clinical outcomes by invigorating CD8<sup>+</sup> T cell-mediated antican...
Main Authors: | Jihoon Kim, David M. Francis, Susan N. Thomas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/11/2/471 |
Similar Items
-
Comparative Large Amplitude Oscillatory Shear (LAOS) Study of Ionically and Physically Crosslinked Hydrogels
by: Thomas B. Goudoulas, et al.
Published: (2023-03-01) -
In situ crosslinkable hydrogels for engineered cellular microenvironments
by: Kyung Min Park, et al.
Published: (2017-09-01) -
In situ Crosslinkable Thiol-ene Hydrogels Based on PEGylated Chitosan and β-Cyclodextrin
by: Mehmet Arslan, et al.
Published: (2018-11-01) -
Impact of the Type of Crosslinking Agents on the Properties of Modified Sodium Alginate/Poly(vinyl Alcohol) Hydrogels
by: Katarzyna Bialik-Wąs, et al.
Published: (2021-04-01) -
Combination of immune checkpoint blockade and targeted gene regulation of angiogenesis for facilitating antitumor immunotherapy
by: Jing Zhan, et al.
Published: (2023-03-01)